<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37491810</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2396-9881</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>European stroke journal</Title><ISOAbbreviation>Eur Stroke J</ISOAbbreviation></Journal><ArticleTitle>Risk of ischemic stroke in patients recovered from COVID-19 infection: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>915</StartPage><EndPage>922</EndPage><MedlinePgn>915-922</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/23969873231190432</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Data regarding the risk of ischemic stroke within 1&#x2009;year after the post-acute phase of COVID-19 remain scant. We assess the risk of ischemic stroke in COVID-19 survivors after SARS-CoV-2 infection by performing a systematic review and meta-analysis of the available data.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Following the PRISMA guidelines, we searched Medline and Scopus to locate all articles published up to February 11, 2023, reporting the risk of incident ischemic stroke in adult patients recovered from COVID-19 infection compared to non-infected patients (controls) defined as those who did not experience the infection over the same follow-up period. Ischemic stroke risk was evaluated using the Mantel-Haenszel random effects models with adjusted Hazard ratio (HR) as the effect measure with 95% confidence interval (CI) while heterogeneity was assessed using Higgins <i>I</i><sup>2</sup> statistic.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Overall, 23,559,428 patients (mean age 56, 1&#x2009;year, 54.3% males), of whom 1,595,984 had COVID-19, were included. Over a mean follow-up of 9.2&#x2009;months, ischemic stroke occurred in 4.40 [95% CI: 4.36-4.43] out of 1000 patients survived to COVID-19 compared to 3.25 [95% CI:3.21-3.29] out of 1000 controls. Recovered COVID-19 patients presented a higher risk of ischemic stroke ((HR: 2.06, 95% CI: 1.75-2.41, <i>p</i>&#x2009;&lt;&#x2009;0.0001, <i>I</i><sup>2</sup>&#x2009;=&#x2009;63.7%) compared to people who did not have COVID-19. COVID-19 patients hospitalized at the time of the infection have a subsequent higher risk of stroke during the follow-up compared to those non-hospitalized.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Recovered COVID-19 patients have a higher risk of ischemic stroke compared to subjects from the general population within 9&#x2009;months from the index infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zuin</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4559-1292</Identifier><AffiliationInfo><Affiliation>Department of Translational Medicine, University of Ferrara, Ferrara, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, West Vicenza Hospitals, Arzignano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzitelli</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infectious and Tropical Diseases Unit, Padua University Hospital, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rigatelli</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ospedali Riuniti Padova Sud, Monselice, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilato</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West Vicenza Hospitals, Arzignano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cattelan</LastName><ForeName>Anna Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Infectious and Tropical Diseases Unit, Padua University Hospital, Padua, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Stroke J</MedlineTA><NlmUniqueID>101688446</NlmUniqueID><ISSNLinking>2396-9873</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword></KeywordList><CoiStatement>Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>27</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>26</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37491810</ArticleId><ArticleId IdType="pmc">PMC10372514</ArticleId><ArticleId IdType="doi">10.1177/23969873231190432</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Drake TM, Riad AM, Fairfield CJ, et al..; ISARIC4C investigators. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO clinical characterisation protocol UK: a prospective, multicentre cohort study. Lancet 2021; 398: 223&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285118</ArticleId><ArticleId IdType="pubmed">34274064</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M, Rigatelli G, Bilato C, et al.. Heart failure as a complication of COVID-19 infection: systematic review and meta-analysis. Acta Cardiol 2022; 77: 107&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">34080948</ArticleId></ArticleIdList></Reference><Reference><Citation>Mensah GA, Vaduganathan M, Roth GA. Acute cardiovascular complications of COVID-19: the high risk of underlying heart disease. J Am Coll Cardiol 2023; 81: 570&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9901496</ArticleId><ArticleId IdType="pubmed">36754517</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan BWL, Tan BWQ, Tan ALM, et al.. Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: an international multi-centre observational cohort study. EClinicalMedicine 2022; 55: 101724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9640184</ArticleId><ArticleId IdType="pubmed">36381999</ArticleId></ArticleIdList></Reference><Reference><Citation>Polverino F, Stern DA, Ruocco G, et al..; ItaliCO Study Group. Comorbidities, cardiovascular therapies, and COVID-19 mortality: a nationwide, Italian Observational Study (ItaliCO). Front Cardiovasc Med 2020; 7: 585866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7583635</ArticleId><ArticleId IdType="pubmed">33195473</ArticleId></ArticleIdList></Reference><Reference><Citation>Nannoni S, de Groot R, Bell S, et al.. Stroke in COVID-19: a systematic review and meta-analysis. Int J Stroke 2021; 16: 137&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7859578</ArticleId><ArticleId IdType="pubmed">33103610</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavda V, Chaurasia B, Fiorindi A, et al.. Ischemic stroke and SARS-CoV-2 infection: the bidirectional pathology and risk morbidities. Neurol Int 2022; 14: 391&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9149929</ArticleId><ArticleId IdType="pubmed">35645351</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghayari Sheikh Neshin S, Shahjouei S, Koza E, et al.. Stroke in SARS-CoV-2 infection: a pictorial overview of the pathoetiology. Front Cardiovasc Med 2021; 8: 649922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8039152</ArticleId><ArticleId IdType="pubmed">33855053</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J, Scorza FA, Scorza CA, et al.. Ischemic stroke in 455 COVID-19 patients. Clinics 2022; 77: 100012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8841215</ArticleId><ArticleId IdType="pubmed">35240494</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeratne T, Gillard Crewther S, Sales C, et al.. COVID-19 pathophysiology predicts that ischemic stroke occurrence is an expectation, not an exception&#x2014;A systematic review. Front Neurol 2021; 11: 607221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876298</ArticleId><ArticleId IdType="pubmed">33584506</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez KE, Rosenberg GA. Shared inflammatory pathology of stroke and COVID-19. Int J Mol Sci 2022; 23: 5150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9101120</ArticleId><ArticleId IdType="pubmed">35563537</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Castelnuovo A, Costanzo S, Antinori A, et al.. Heparin in COVID-19 patients is associated with reduced In-hospital mortality: the multicenter Italian CORIST study. Thromb Haemost 2021; 121: 1054&#x2013;1065.</Citation><ArticleIdList><ArticleId IdType="pubmed">33412596</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlpine LS, Zubair AS, Maran I, et al.. Ischemic stroke, inflammation, and endotheliopathy in COVID-19 patients. Stroke 2021; 52: e233&#x2013;e238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8140646</ArticleId><ArticleId IdType="pubmed">33966492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakarla V, Kaneko N, Nour M, et al.. Pathophysiologic mechanisms of cerebral endotheliopathy and stroke due to Sars-CoV-2. J Cereb Blood Flow Metab 2021; 41: 1179&#x2013;1192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8142132</ArticleId><ArticleId IdType="pubmed">33530831</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M, Rigatelli G, Zuliani G, et al.. Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19. Lancet 2021; 398: 1303&#x2013;1304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497034</ArticleId><ArticleId IdType="pubmed">34627487</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Ren J, Hou H, et al.. The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates. Neurol Sci 2022; 43: 4049&#x2013;4059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8943353</ArticleId><ArticleId IdType="pubmed">35325320</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Sun W, Wang Y, et al.. Clinical course and mortality of stroke patients with coronavirus disease 2019 in Wuhan, China. Stroke 2020; 51: 2674&#x2013;2682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434009</ArticleId><ArticleId IdType="pubmed">32755348</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri H, Strasser ZH, Brat GA, et al.. Evolving phenotypes of non-hospitalized patients that indicate long COVID. BMC Med 2021; 19: 249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8474909</ArticleId><ArticleId IdType="pubmed">34565368</ArticleId></ArticleIdList></Reference><Reference><Citation>Tleyjeh IM, Saddik B, AlSwaidan N, et al.. Prevalence and predictors of post-acute COVID-19 syndrome (PACS) after hospital discharge: a cohort study with 4 months median follow-up. PLoS One 2021; 16: e0260568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8651136</ArticleId><ArticleId IdType="pubmed">34874962</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al..; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>
Wells GA, Shea B, O&#x2019;Connell D, et al.. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses, https://www.ohri.ca/programs/clinical_epidemiology/nosgen.pdf&#x2009;(2012, accessed 29 August 2022).</Citation></Reference><Reference><Citation>Cohen K, Ren S, Heath K, et al.. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ 2022; 376: e068414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Guo Y, Heath K, et al.. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ 2021; 373: n1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B, Sudry T, Flaks-Manov N, et al.. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ 2023; 380: e072529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisi-Estabragh Z, Cooper J, Salih A, et al.. Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank. Heart 2022; 109: 119&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9811071</ArticleId><ArticleId IdType="pubmed">36280346</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan EYF, Mathur S, Zhang R, et al.. Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank. Cardiovasc Res 2023; 119: 1718&#x2013;1727.</Citation><ArticleIdList><ArticleId IdType="pubmed">36652991</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Wang CY, Wang SI, et al.. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks. eClinicalMed 2022; 53: 101619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9366236</ArticleId><ArticleId IdType="pubmed">35971425</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med 2022; 28: 2406&#x2013;2415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisler A, Stirrup O, Pisarev H, et al.. Post-acute sequelae of COVID-19 among hospitalized patients in Estonia: nationwide matched cohort study. PLoS One 2022; 17: e0278057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9683565</ArticleId><ArticleId IdType="pubmed">36417409</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, et al.. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021; 8: 416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Koton S, Schneider ALC, Rosamond WD, et al.. Stroke incidence and mortality trends in US communities, 1987 to 2011. JAMA 2014; 312: 259&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pubmed">25027141</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W, Liu X, Bao K, et al.. Ischemic stroke associated with COVID-19: a systematic review and meta-analysis. J Neurol 2022; 269: 1731&#x2013;1740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8517946</ArticleId><ArticleId IdType="pubmed">34652503</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi AI, Baskett WI, Huang W, et al.. Acute ischemic stroke and COVID-19: an analysis of 27&#x2009;676 patients. Stroke 2021; 52: 905&#x2013;912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903982</ArticleId><ArticleId IdType="pubmed">33535779</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaghi S, Ishida K, Torres J, et al.. SARS-CoV-2 and stroke in a New York healthcare system. Stroke 2020; 51: 2002&#x2013;2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7258764</ArticleId><ArticleId IdType="pubmed">32432996</ArticleId></ArticleIdList></Reference><Reference><Citation>van Walraven C, Hawken S. Competing risk bias in Kaplan-Meier risk estimates can be corrected. J Clin Epidemiol 2016; 70: 101&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">26327491</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M, Tate M, Lloyd O, et al.. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe 2021; 2: e13&#x2013;e22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837230</ArticleId><ArticleId IdType="pubmed">33521734</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbonde AA, O'Carroll CB, Grill MF, et al.. Stroke features, risk factors, and pathophysiology in SARS-CoV-2-infected patients. Mayo Clin Proc Innov Qual Outcomes 2022; 6: 156&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8776423</ArticleId><ArticleId IdType="pubmed">35079695</ArticleId></ArticleIdList></Reference><Reference><Citation>Esenwa C, Cheng NT, Lipsitz E, et al.. COVID-19-associated carotid atherothrombosis and stroke. AJNR Am J Neuroradiol 2020; 41: 1993&#x2013;1995.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7658853</ArticleId><ArticleId IdType="pubmed">32819896</ArticleId></ArticleIdList></Reference><Reference><Citation>John S, Kesav P, Mifsud VA, et al.. Characteristics of large-vessel occlusion associated with COVID-19 and ischemic stroke. AJNR Am J Neuroradiol 2020; 41: 2263&#x2013;2268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7963240</ArticleId><ArticleId IdType="pubmed">32855182</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M, Rigatelli G, Bilato C, et al.. Risk of incident new-onset arterial hypertension after COVID-19 recovery: a systematic review and meta-analysis. High Blood Press Cardiovasc Prev 2023; 30: 227&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10105348</ArticleId><ArticleId IdType="pubmed">37060396</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M, Barco S, Giannakoulas G, et al.. Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis. J Thromb Thrombolysis 2023; 55: 490&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9845812</ArticleId><ArticleId IdType="pubmed">36652137</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>